IndiaDCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old By Palak Vaghela 13 May 2021Share Twitter Share Whatsapp LinkedIn
IndiaRussian Vaccine Sputnik V gets emergency use authorisation in India By Palak Vaghela 13 Apr 2021Share Twitter Share Whatsapp LinkedIn
/connect-gujarat-english/media/post_banners/d4f9373e09c68a52491df983e55f5e86566aab874003612e9c87ea2e459a1cbb.webp)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2021/05/9-12.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2021/04/6-20.jpg)